基于网络药理学的策略,用于预测Ecliptae Herba对乳腺癌的治疗目标
Hui Li1,2,3, Wei Shi1,2,3, Tingming Shen4
1School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Medicine
|October 13, 2023
概括
埃克利普泰草 (Ecliptae Herba) 通过向TGFB1.1等关键基因,显示出对抗乳腺癌的潜力. 这项研究揭示了其活性化合物和分子机制,支持其在传统中医中用于癌症治疗的应用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 传统中国医药 传统中国医药
背景情况:
- 乳腺癌是全球主要的健康问题,死亡率高.
- 传统草药Ecliptae Herba表现出有前途的抗瘤特性.
- 了解其活性成分和机制对于治疗开发至关重要.
研究的目的:
- 研究Ecliptae Herba抗乳腺癌作用的物质基础和分子机制.
- 确定关键的活性成分,目标和涉及其疗效的途径.
- 为使用Ecliptae Herba在乳腺癌治疗中提供科学基础.
主要方法:
- 网络药理学被用来分析活性成分和标.
- 超高性能液体染色学-并联质谱学 (UPLC-MS/MS) 识别的化合物.
- 生物信息学工具 (STRING,Metascape,R软件) 和分子对接被用于目标和途径分析.
- 细胞学实验验证了关键发现,特别是TGF-β1.1的作用.
主要成果:
- 从Ecliptae Herba中确定了178种活性成分和3431种乳腺癌标.
- 发现了144个交叉目标,其中EGFR和TGFB1被确定为关键的枢纽基因.
- 网络药理学分析表明,Ecliptae Herba参与了多种与癌症有关的途径.
- 分子对接证实了活性成分和关键标之间良好的结合亲和力.
- 实验验证证了TGF-β1作为关键目标,TGF-β1/Smad通路作为关键机制.
结论:
- 埃克利普草 (Ecliptae Herba) 含有多种活性成分,可以向乳腺癌中的关键基因.
- TGF-β1/Smad信号通路是Ecliptae Herba发挥其抗乳腺癌作用的重要机制.
- 这项研究为Ecliptae Herba在传统中医中预防和治疗乳腺癌的应用提供了科学基础.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K